Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis
Open Access
- 1 July 2005
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 45 (1) , 87-93
- https://doi.org/10.1016/j.femsim.2005.02.009
Abstract
Activation of mucosal immunity in the respiratory tract is crucial for protection against respiratory infections. Whether the intranasal route of vacKeywords
This publication has 23 references indexed in Scilit:
- Nasal vaccinesAdvanced Drug Delivery Reviews, 2001
- Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigensVaccine, 2001
- Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunityVaccine, 2001
- Protective Immunity toStreptococcus mutansInduced by Nasal Vaccination with Surface Protein Antigen and Mutant Cholera Toxin AdjuvantThe Journal of Infectious Diseases, 2001
- Is the development of a new tuberculosis vaccine possible?Nature Medicine, 2000
- ESAT-6 Subunit Vaccination againstMycobacterium tuberculosisInfection and Immunity, 2000
- Variation in protection by BCG: implications of and for heterologous immunityThe Lancet, 1995
- DDA as an immunological adjuvantResearch in Immunology, 1992
- SINGLE-DOSE ANTENATAL TETANUS IMMUNISATIONThe Lancet, 1973
- STUDIES ON THE POLYGLYCEROLPHOSPHATIDE OF MYCOBACTERIUM TUBERCULOSISCanadian Journal of Biochemistry, 1964